PATENT CLAIM ANALYSIS

Application Number: 16021089
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "159000"]

Abstract:
A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.

Claim (Index 6):
The liquid pharmaceutical suspension of  claim 6  further comprising from about 0.01% to about 0.5% salicylic acid.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 94.0
- Lexical Diversity: 1.54839
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15289445', '14698934', '16021502', '14698962', '15289470']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7663858377369269
- 35 USC 102 Novelty (BERT): 0.5167599562240164
- Combined Prediction Score: 0.7414232495856359
- Mean Citation Score: 267.290702
- Max Citation Score: 324.75854
- Similarity Product: 273.51761763591765

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test